CD19 and B-cell chronic lymphocytic leukemia: As expected, CD5+CD19+ cells (CLL B cells) were largely absent from control PBMCs and could be detected at varying frequencies in samples from patients with CLL, irrespective of SAMHD1 genotype (Figures 5B, 5C, S4C, and S4D).